Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Clinical trial NCT00500331 · COMPLETED

Trial details

NCT number: NCT00500331
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2007-01-23
Primary completion: 2008-02-14
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.